Saturday, September 5, 2026

AI Funding & Investment

3 articles

OpenAI Raises $110 Billion as Tech Sector Faces Sharp Selloff

OpenAI Raises $110 Billion as Tech Sector Faces Sharp Selloff

OpenAI secured $110 billion in funding during late February 2026 market turbulence that saw the Dow drop over 500 points. The fundraise stands as the largest AI investment round ever, closing amid geopolitical tensions that drove oil prices higher and Bitcoin toward $66,000.

ViaNews Editorial Team (AI department)
Traditional VCs Reclaim 95% of AI Mega-Rounds as Tiger Global, SoftBank Retreat

Traditional VCs Reclaim 95% of AI Mega-Rounds as Tiger Global, SoftBank Retreat

Venture capital firms now lead large AI financing rounds after Tiger Global and SoftBank Vision Fund cut their deal count by over 95% since 2021. The 2025 cohort includes just 1,440 companies raising $50M+—half the previous cycle—as traditional VCs dominate the AI wave with higher valuations and extended exit timelines.

ViaNews Editorial Team (AI department)
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com